Frederic Geoffrey Albert Destin

Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom.

Streetbees.com Ltd. market research services. The company was founded by Tugce Balut and Oliver Henry May on August 15, 2014 and is headquartered in London, the United Kingdom.

Ubiquisys Ltd. provides communication services. The company was founded on October 1, 2004 and is headquartered in Cardiff, the United Kingdom.

PhotoBox Ltd. provides online photo printing, sharing and personal publishing. Its products include prints, photo books, wall decor, cards, stationery and home gifts. The company was founded by Martin Genot, Graham Hobson, Michel de Guilhermier, and Mark Chapman in 2000 and is headquartered in London, the United Kingdom.

Xelerated provides technology solutions for the networking industry. The company helps network equipment vendors build high-speed programmable carrier-class systems for prolonged product life times, streamlined R&D and accelerated time-to-market. Xelerated implements the Dataflow Architecture in network processors and programmable Ethernet switches that are manufactured by world leading fabs. The devices set a new benchmark for packet processing devices. In support to its customers' engineering efforts, the firm provides an array of software products and services to help them customize its technology in order to match the system designs and product innovations they envision.

Deutsche Bank AG provides corporate banking and investment services. It offers asset and wealth management, corporate banking and securities and global transaction banking solutions. The company was founded in 1873 and is headquartered in London, the United Kingdom.

Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom.

Accel Partners Ltd. operates as a credit institution which provides financial services. It offers its services to the private, corporate and government sectors. The company was founded on July 11, 2000 and is headquartered in London, the United Kingdom.

MyThings, Inc. provides custom programmatic advertisement solutions. It specializes in retargeting campaigns on desktop and mobile platforms. The firm’s services include data mining, analytics dashboard, consumer database, and segmentation engine solutions. The company was founded by Ben Z. Arbel in 2005 and is headquartered in New York, NY.

Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom.

Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.

EVE SA provides electrical installation work on public roads. The company was founded in April 2000 and is headquartered in Paris, France.

Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector.

SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands.

Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.

Outrun Therapeutics Ltd. is a British biotechnology company founded in 2019 that develops a platform for drug discovery.

Campanja AB provides search engine marketing platform. Its products include Google shopping solution and visitor tracking. The company was founded by Marcus Richard Leopold Anzengruber and Berner Setterwall in 2010 and is headquartered in Stockholm, Sweden.

Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands.

iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland.

Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC.

Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.

Spotfire, Inc. provides analytic software solutions. It creates software that transforms complex data into images that reveal the relationships between pieces of information. The firm also offers installation, training workshops, and technical support services. The company was founded by Jonas Lagerblad and Christopher Ahlberg in 1996 and is headquartered in Boston, MA.

Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA.

OTA Insight provides tools for optimizing hotel ranking on online travel agency websites. It offers hotel market forecast through the use of a data system and a forecasting algorithm that tracks all in-market online inventory giving visibility of future market. The company was founded by Matthias Geeroms, Adriaan Coppens and Gino Engels in 2012 and is headquartered in London, the United Kingdom.

HCI/TCP OTA Holding Ltd. is a British company that provides cloud-based data platform software licenses to the hospitality management industry. The private company is based in London, UK. The company was founded in 2017.

Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands.

Smol Ltd. provides laundry services. Its products include dishwash and fabcon. The company is headquartered in Crawley, the United Kingdom.

Wendel SE (Private Equity) is the Private Equity arm of the Wendel Group (MF) founded in 1977. Wendel SE is headquartered in Paris with additional offices around the world.

Winvest Interational SA Sicar invests in internationally-oriented companies located in the Benelux, France, and Germany. The fund targets companies operating across a broad range of sectors. It provides financing for MBOs, MBIs, and expansion stage capital requirements.